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Abstract  This paper is a review with more than 100 references discussing the 
immunochemical methods reported in the literature for the most important man-made 
chemicals with suspected endocrine disrupting activity. Details regarding immunizing 
hapten design, antibody production, and the features (limit of detection, dynamic range, 
specificity) of the most important immunochemical methods developed (ELISA, FIIA, 
immunosorbents, immunosensors, etc.) are presented for important environmental 
pollutants such as bisphenol A, phthalates, alkylphenol polyethoxylates, alkylphenols, 
polychlorinated biphenyl compounds, and dioxins. Availability of commercial reagents 
and methods is reported. 
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Introduction 
During recent decades much attention has been concentrated in the study of the health 
effects and risk assessment of many natural and synthetic substances in wildlife and 
humans. In particular, great concern has been focused on certain man-made substances 
that are capable of interaction with the estrogen receptor, induce a biological response, 
and cause a disruption in the endocrine system of animal and human organisms (for 
reviews see refs. [1, 2, 3, 4, 5, 6, 7, 8, 9]). The endocrine system is responsible for 
practically all the important functions in the organisms such as sexual differentiation, 
sexual maturation during puberty, growth reproduction, and behavior, and it is 
controlled by hormones. Besides the natural substances (like estrogens, progesterone, 
and testosterone in humans and animals or the phytoestrogens in some plants) there are 
a large number of synthetic compounds known as endocrine disruptors chemicals 
(EDCs) that can interact in different ways with the endocrine system. Mechanisms of 
action include mimicking or antagonizing the effect of endogenous hormones, 
interfering in the production and metabolism of endogenous hormones, or disrupting the 
synthesis of hormone receptors. Some of these compounds are synthetic hormones (e.g., 
ethynylestradiol, synthetic androgenic substances, etc.) produced to specifically interact 
with the hormonal receptor (contraceptive pill, growth-promoters used for meat 
production, etc.). However, most of them are man-made chemicals of industrial origin, 
with diverse chemical structures and are produced with different purposes far away 
from the endocrine action. Some others are by-products of industrial processes (e.g., 
dioxins). These substances are generating great concern within the public and scientific 
community [10, 11]. In the final report of the European Commission towards the 
establishment of a priority list of EDCs [12], from 564 suspected substances, 146 were 
selected because of their persistence or high production volume. From these, 
66 substances (35 chemical groups) were categorized into category 1 (at least one study 
provides evidence of endocrine disruption in an intact organism) and 60 substances (29 
chemical groups) were considered to be of high human and wildlife exposure concern. 
These include substances such as some pesticides (maneb, metam, zineb, etc.), 
polychlorinated biphenyls (PCBs), dichlorodiphenyltrichloroethane (DDT), dioxins 
(PCDDs), and furans (PCDFs), polybrominated diphenyl ethers (PBDE), alkylphenolic 
compounds such as octylphenol (OP), nonylphenol (NP) and their short-chain 
ethoxylated derivatives (APEs), phthalate esters (PE), and bisphenol A (BPA). 
The type of endocrine disrupting activities reported for these substances are effects in 
the uterus, testes, prostate, or other sex organ weights, in sperm development, vaginal 
opening, thyroid hormone levels, and neuroendocrine pituitary effects. Although the 
hormonal effects of most of them are weak (the estrogenic activity it ranges from 
1/1,000th to 1/11,000,000th compared with estradiol), many effects have been observed 
in wildlife species exposed to these chemicals, such as an abnormal development of the 
reproductive organs and reproductive disorders in fish. Moreover, an increase of the 
incidence of testicular and prostate cancers in males and breast cancer and 
endometriosis in females has been suggested to be related to an exposure to these 
substances [9, 13]. Another important consideration that must be taken into account is 
the presence of multicomponent mixtures of xenoestrogens. Although it seems that 
synergisms are not produced, the additive combination effects of these EDCs have been 
observed at individual concentrations which are lower than their no observed effect 
concentration value (NOEC)[14]. 
All evidence observed during recent years raises the need for a continuous development 
of effective methods for risk and environmental assessment of these substances. 
Specific and sensitive techniques for the detection of EDCs in environmental samples 
are required to increase environmental monitoring efficiency and to protect public 
health from the adverse effects that potentially may result. The key requirements for 
environmental monitoring and analysis are the limit of detection and the selectivity but 
also other aspects such as time per sample analysis, sample pretreatment requirements, 
the cost of equipment and maintenance, and the operator skills. 
Analytical tools based on conventional techniques such as gas or liquid chromatography 
(GC and LC) coupled to sensitive detection systems such as mass spectrometry (MS) or 
MS-MS have been applied to detect EDCs. Unfortunately, most of these techniques are 
time-consuming and have elevated cost due to the fact that extensive clean-up and 
sample treatment methods that often involve derivatization procedures are required. 
Alternatively, immunochemical techniques offers a large number of advantages, the 
most relevant being the selectivity and sensitivity shown by the specific antibodies for 
the target analyte, the use of small sample volumes, the low cost, and the simplicity of 
the methodologies. Moreover, they are easily adapted to automated systems and to 
development of high-throughput screening (HTS) methods. In this paper a review of the 
immunochemical methods developed for the determination of man-made EDCs in 
environmental samples is reported. For analytical methods used to determine natural or 
synthetic steroids hormones the reader is referred to other published literature [15, 16]. 
A variety of immunochemical methods against those hormones have also been reported 
[17, 18, 19, 20, 21, 22, 23] and several antibodies (both monoclonal and polyclonal) and 
immunoassay kits are commercially available. Therefore, only those substances from 
industrial origin will be treated in this paper. A short introduction to the most common 
immunochemical techniques applied for environmental monitoring will be presented 
initially. Particular attention has been paid to immunochemical methods reported for 
those EDCs rated as high to medium risk of exposure for the human and wildlife 
population, as occurs with APEs, PE, BPA, PCBs, PCDDs and PCDFs. We will not go 
through the immunochemical determination of pesticides with suspicious ED activity, 
since the reader may find other reviews dealing with this topic [21, 24, 25, 26, 27]. 
 
Immunochemical methods 
Immunochemical techniques are based on the specific interaction between antibodies 
and antigens. Although the principles of the immunological reaction are not new, there 
has been important progress in the development of these methodologies in recent years 
owing to the availability of antibodies for a great variety of foreign low-molecular-
weight molecules, macromolecules, drugs, and proteins. Small molecules themselves 
are generally not capable of stimulating the immune response in the host animal. 
Therefore, synthesis of an analogue of the target analyte (the immunizing hapten) is 
required in order to conjugate it to a carrier protein. The choice of a suitable hapten, 
which should keep the most characteristic groups of the analyte without altering, as far 
as possible, their electronic and geometric features, is the key step in the production of 
good antibodies [28]. During recent years specific antibodies have been obtained for a 
large variety of pesticides, xenobiotics, and other kinds of environmental pollutants, and 
innovative immunochemical approaches have been developed based on the Ab–Ag 
reaction [29, 30]. The more relevant ones are briefly detailed below. 
Immunoassays 
The most widely used immunochemical method for pollutant detection is the 
immunoassay (IA) [31, 32, 33, 34]. This method is based on the use of labels to detect 
the reaction Ab–Ag. These assays can be run in homogeneous or heterogeneous formats. 
In the former, all the immunoreagents are in solution, and there is no separation between 
the free (Ag and Ab) and the bound phase (Ag–Ab-labeled and nonlabeled) before the 
detection step. In the heterogeneous format, one of the immunoreagents is immobilized 
on a solid support, which facilitates the isolation of the bound fraction (Ag–Ab). 
Homogeneous formats are often less sensitive but the simplicity of the format makes 
them very useful for applications in process monitoring. Several markers such as 
chemiluminescent or fluorescent molecules are used as labels, and novel techniques 
have emerged such as the competitive binding chemiluminescent immunoassay (CLIA), 
competitive binding fluoroimmunoassays (FIA), time-resolved fluroimmunoassay 
(TRFIA), and polarization fluorescent immunoassay (PFIA). Most of these operate in 
homogeneous formats. However, the most common labels are still enzymes, the most 
frequently used being horseradish peroxidase (HRP) and alkaline phosphatase (AP). 
Within these enzyme immunoassays (EIAs), the heterogeneous format is the most 
common and it is referred to as enzyme-linked immunosorbent assays (ELISAs). When 
the analytes are small molecules the immunoassays must work under competitive 
configurations. A competition takes place between a free antigen (or analyte, Ag) and a 
labeled Ag (Ag*) for a fixed and limited amount of specific Ab. At the final step, the 
amount of labeled Ag can be measured, and subsequently, the free Ag. A short 
description of the most common immunoassay formats employed for environmental 
analysis is presented below. 
Fluoroimmunoassays (FIAs) and chemiluminescent 
immunoassay (CLIAs) 
Several FIAs and CLIAs have been developed for detection of environmental pollutants 
[35, 36, 37]. Fluorescent labels such as fluorescein, rhodamine, Eu(III), Tb(III), and 
Sm(III) chelates, or chemiluminescent substances such as luminol are used in these 
immunoassays . In FIAs, the sensitivity may be limited by the background noise of 
some samples. Often the fluorophore is generated enzymatically rather than using it 
directly in order to improve sensitivity by taking advantage of the enzyme turnover. 
FIAs have often been adapted to flow-immunoassays systems (FIIA) in which the assay 
takes place on small reactors to which samples and reagents (antibodies, labeled 
antigens, etc.) are delivered in an automated mode (see below). 
Polarization fluorescent immunoassays (PFIAs) 
These homogeneous immunoassays are based on the difference in a rotational 
movement between the bound and the free labeled antigen (tracer). When a specific 
antibody binds a fluorophore-labeled hapten, an increase in fluorescent polarization is 
observed. Similarly, the signal decreases when the free analyte competes for binding to 
the Ab. Usually these assays are less sensitive than EIAs but are very useful for sample 
screening [38, 39, 40]. 
Enzyme-linked immunosorbent assay (ELISA) 
These heterogeneous assays can be found on a great variety of modes and formats. 
ELISAs have been described that are performed in tubes, plastic-baked nitrocellulose 
membranes, magnetic particles, etc., but most often 96-well microtiter plates are 
preferred since these allow the simultaneous analysis of a large number of samples. 
Depending on the immunoreagent immobilized on the plate, two main formats can be 
distinguished when small molecules are analyzed: the direct and indirect. In the direct 
format, the Ab is usually coated on the active surface and equilibrium is established 
between the analyte and the enzyme tracer for binding to the Ab. The unbound reagents 
are washed away and the amount of tracer is measured. The enzyme activity is inversely 
proportional to the amount of analyte present. In the indirect format the Ag is 
immobilized and the amount of analyte is indirectly measured by the quantification of 
the bound Ab with a second labeled Ab. There are examples of ELISA for a large 
number of pollutants, such as carbamates, organochlorine and organophosphorous 
compounds, triazines, PAHs, PCBs, etc. [33]. 
Flow-injection immunoassays (FIIA) 
Flow-injection immunoassays systems (FIIA) [41, 42, 43] offer an interesting 
alternative to classical immunoassay by combining the immunochemical principles with 
the flow-injection methodologies. The automation of the technique allows the screening 
of a large number of samples and real-time monitoring data, often without any lost of 
the detectability accomplished by a traditional ELISA method. In these assays the 
sample is incorporated in a carrier stream which enters in a reactor chamber where the 
immunological reaction takes place. Some FIIAs have been developed for the analysis 
of several pollutants such as pesticides [41, 44, 45, 46] and other industrial pollutants 
such as PCBs [47], thereby demonstrating that FIIAs can be more precise and rapid than 
an ELISA offering automation with low cost. 
Immunoaffinity chromatography 
Immunoaffinity chromatography (IAC) [48, 49] combines the immunochemical reaction 
Ab–Ag with solid-phase extraction techniques. The specific Ab is covalently 
immobilized on an activated solid support (usually agarose, polyacrylamide, polyacrylic, 
etc.) and is then packed in small cartridges. These columns specifically retain the target 
analyte. The non-specifically bound compounds are removed and the analyte can then 
be eluted when appropriate desorption conditions have been found and optimized 
(usually introducing changes in the buffer composition, such as the pH, the ionic 
strength, and the ratio of organic solvent). This technique can be used as a clean-up 
pretreatment to remove the interferences. These substances can cause possible matrix 
effects when complex environmental samples are analyzed off-line with conventional 
methods such as HPLC, GC, or even with IAs (immunoassays). Some examples of this 
application can be found in the literature for some pesticides [50, 51, 52, 53, 54]. 
Immunosensors 
There are several kinds of biosensor depending on the biological recognition element 
(i.e., enzymes, whole cells, receptors, DNA, etc.) and the transducing principle 
employed (piezoelectric, electrochemical, thermistor, or optical [55, 56, 57, 58]). On 
immunosensors the biological component can be either a specific antibody or the 
antigen. The biomolecule is immobilized on a physical transducer capable of 
transforming the physicochemical changes (dielectric constant, weight, charge, pH, etc.) 
produced when the immunoreaction Ag–Ab takes place on the active surface into a 
measurable electrical signal. The current requirements needed for the analysis of trace 
substances and pharmaceuticals in food industries and in clinical areas [59] have made 
of the immunosensors interesting alternatives that may provide fast, highly sensitive, 
specific, and automated analytical devices, continuous monitoring systems, etc. 
Although the most well known of these is the glucose sensor and other sensors 
employed for medical diagnoses, several immunosensors have also been developed for 
the detection of pesticides [60, 61, 62] and pollutants [63, 64]. 
 
Immunochemical methods for EDC analysis 
In the following sections, the most important chemical groups from industrial origin 
with demonstrated estrogenic effects will be presented and discussed in terms of 
published immunochemical methods available today. 
Alkylphenolic compounds 
Within the nonionic surfactants, the most important one is the group of alkylphenol 
polyethoxylates (APEs). They have been widely used in detergent formulations, both 
domestic and industrial, for many years. Other areas where these surfactants have been 
applied comprise the pulp and paper industry, pesticide formulations, in the leather and 
fur industry, and in the area of pharmaceutical and personal care products (PPCPs). The 
most common APEs are those produced from nonylphenol (nonylphenol 
polyethoxylates, NPEs) and octylphenol (octylphenol polyethoxylates, OPEs). 
Alkylphenols themselves have also been used as plasticizers and stabilizers in plastics. 
Worldwide production is about 500,000 t [65], which represents 8% of the total 
production of surfactants used in the USA, Japan, and Western Europe [66]. This 
considerable consumption of these nonionic surfactants involves great levels of 
discharges of APEs into the environment. In the wastewater treatment plants (WWTPs) 
the APEs are readily biodegraded under both aerobic and anaerobic conditions [67] 
losing most of the ethoxylate units; the final breakdown products are APEs with one or 
two ethoxylate groups (AP1EO, AP2EO), alkylphenoxy carboxylic acid (APEC), and 
APs. These products have lost their surfactant properties and can persist for longer time 
in the environment. The more polar APECs can persist in wastewater, effluents, and 
rivers. APs and short-chain APEs are more lipophilic and persist mainly in soils, 
sediments, and sludge [68, 69, 70]. 
Whilst long-chain APEs seem to present low toxicity in organisms, APs, both OP and 
NP, have been revealed as much more toxic with a demonstrated estrogenic effect [71, 
72, 73]. The environmental levels of these compounds may exceed the predicted no 
effect concentration (PNEC) of 0.33 μg L–1 [68] proposed in a risk assessment report to 
the European Union. Although disagreements were previously observed over risks of 
these surfactants, nowadays, several regulatory measures have been taken both in 
Europe and USA. For instance many European countries have banned the use of APs in 
domestic applications and APEs have been substituted for less toxic surfactants such as 
alcohol ethoxylates (AEs). In the USA, serious regulatory actions are now being taken 
into account related to domestic use of APEs. 
This current increasing concern has led to the development of specific, sensitive, and 
rapid techniques for their detection. Many conventional methods based on HPLC and 
GC coupled to a MS detector have been optimized to give good levels of sensitivity [74, 
75] in the range of ng L
–1
. 
Immunochemical techniques for APEs and APs 
Few references have been found in the literature related to specific antibodies against 
APEs. Goda et al. [76, 77] reported the production of monoclonal antibodies 
recognizing both APEs and APs (NP and OP) to the same extent. The chosen 
immunizing hapten retained the alkyl chain (the nonyl chain) intact and was derivatized 
keeping five ethoxylates groups (EO) in the molecule (see hapten 1A in Scheme 1). A 
microtiter plate direct ELISA was developed. Preparation of the antibody-coated plate 
involved several steps including two overnight blocking steps and the competitive assay 
was then run in 90 min. The sensitivity obtained for NP is not extremely good, with a 
limit of detection (LOD) of 10 μg L-1 (see Table 1). Long- (EO=10), medium- (EO=5–
7), and short-chain (EO=1,2) APEs and APs (both NP and OP) are also well recognized. 
This lack of specificity has the disadvantage that overestimated values are obtained 
when the estrogenic NP levels are determined; however, it can be useful as a screening 
method. This assay and the monoclonal antibodies have been commercialized by 
Takeda Industries (Japan) [78]. The ELISA kit specifications indicate that APECs 
(NP2EC, NP3EC) are highly recognized (near 400% considering NP as 100%). These 
results are consistent, since the immunizing hapten is in essence a NPEC. This company 
has also developed another monoclonal antibody specific only for APEs with more than 
two ethoxylate units; AP, AP1EO, and AP2EO are not recognized [78]. The working 
range is similar to that obtained in the aforementioned case (see Table 1). In both cases 
other relevant surfactants such as linear alkylbenzene sulfonates (LAS), which could 
interfere in environmental samples from wastewater or effluents, are not recognized. 
Thus, the combination of both assays allows the determination of total concentration of 
these last three metabolites of APEs.  
 
Scheme 1A,B  Chemical structures of the immunizing haptens used to raise antibodies for 
APEs and AP. A Hapten used by Goda et al. [76] to obtain monoclonal antibodies. B Hapten 
used by Franek et al. [79] to obtain polyclonal antibodies  
 
Table 1  Immunochemical techniques developed for the detection of APEs and AP  
Compound 
Immunochemical 
technique 
LOD
a
/IC50
b 
(μg L–1) 
Working range 
(μg L–1) 
Comments Ref 
NP Direct ELISA 10
a
  70–1,000 
Monoclonal Ab Both APEs and 
APs are well recognized 
[76] 
NP 
Commercial Direct 
ELISA Kit 
nr
c
  5–500 
Monoclonal Ab OP, NPEs, OPEs, 
and NPECs are strongly 
recognized 
[78] 
APEs 
Commercial Direct 
ELISA Kit 
nr 50–2,000 
Monoclonal Ab APEs with EO 
between 2–10 are recognized 
[78] 
NP10EO FIIA 2.4
a
  5–250 Commercial monoclonal Ab  
[79] 
NP10EO Direct ELISA 8.9
a
  10–500 Commercial monoclonal Ab 
NP FIIA 52
a
  100–5,000 Commercial monoclonal Ab  
NP Direct ELISA 76
a
  250–10,000 Commercial monoclonal Ab  
NP Direct ELISA 769
b
  nr 
Commercial ELISA plates with 
Ab immobilized /( -Gal tracer) 
[80] 
NP CIA-GDH biosensor 4,481
b
  nr Commercial monoclonal Ab 
OP Direct ELISA 346
b
  nr 
Commercial ELISA plates with 
Ab immobilized/( -Gal tracer) 
OP CIA-GDH biosensor 1,560
b
  nr Commercial monoclonal Ab 
NPE Direct ELISA 104
b
  nr 
Commercial ELISA plates with 
Ab immobilized( -Gal tracer) 
NPE CIA-GDH biosensor 378
b
  nr Commercial monoclonal Ab 
OPE Direct ELISA 42
b
  nr Commercial ELISA plates with 
Compound 
Immunochemical 
technique 
LOD
a
/IC50
b 
(μg L–1) 
Working range 
(μg L–1) 
Comments Ref 
Ab immobilized( -Gal tracer) 
OPE CIA-GDH biosensor 605
b
  nr Commercial monoclonal Ab 
NPE Automated BMP-IA 6.6
a
  6.6–66,000  Commercial monoclonal Ab  [81] 
NP Indirect ELISA 590
b
  nr Polyclonal Ab 
[79] 
NP PFIA 
42,000
b
, 
7,900
a
  
nr Polyclonal Ab 
a
 LOD limit of detection 
b
IC50  
c
 nr not reported 
CIA-GDH biosensor capillary immunoassay coupled to a glucose dehydrogenase biosensor 
ELISA enzyme linked immunosorbent assay 
BMP-IA bacterial magnetic particles based immunoassay 
FIIA flow-injection immunoassay 
PFIA polarization fluoroimmunoassay 
Several methodologies have been developed using these available monoclonal 
antibodies [79, 80, 81], all of them with the purpose of developing automated systems. 
The main results are shown in Table 1. Franek et al. have developed a generic FIIA for 
both NP and NPE10 [79]. The incubation step between the antibody, the analyte, and 
the labeled Ag (Ag*) is carried out off-line for a short time and then is injected in the 
flow system. The antibody is then retained in a protein G packed column, whereas 
unbound Ag* is eluted and measured. Despite of the competition step, the system can 
be considered fully automated and allows the analysis of 10 samples h
–1
. They have 
compared their system with the direct ELISA using the same kind of labels (in this case, 
the β–galactosidase, β-Gal) and the sensitivities accomplished are similar in both 
methods (see Table 1), and even slightly better for FIIA. 
Another developed method consists of a capillary immunoassay coupled to an enzyme 
biosensor as the detector unit [80]. The system does not run fully automated, since the 
heterogeneous competition step and the elution of the unbound fraction are performed 
off-line. The capillary is then integrated in a flow-injection system with a GDH (glucose 
dehydrogenase) biosensor. The technique has been developed for NP, OP, NPE, and 
OPE, and the sensitivities have also been compared with the direct ELISA. The 
sensitivity is lower in the automated system; however, the specificity results showed the 
same trend (APEs are better recognized than APs) (see Table 1). 
Matsunaga et al. have developed an automated heterogeneous immunoassay based on 
the immobilization of the monoclonal antibodies (from Takeda Industries) on bacterial 
magnetic particles [81] (i.e., magnetite particles synthesized by magnetic bacteria). The 
magnetic properties of these particles permit the easy separation of the immobilized 
reagent from the media in different sequential steps. Competitive assays have been 
carried out using APEs as the target analyte to obtain limits of detection which were 
quite good (LOD=6.6 μg L–1) (see Table 1) compared with the direct ELISA [76]. The 
system also studied the pattern of cross-reactivity with AP itself and APEs individually 
and the same profile was observed as in commercial indications of the direct ELISA 
(i.e., APEs are better recognized than APs). 
At present, only one other attempt has been reported regarding preparation of specific 
antibodies for APEs, in this case, polyclonal antibodies [79]. Several immunizing 
haptens were synthesized with a spacer arm in the alkyl position keeping the phenol 
group intact (hapten 1B in Scheme 1), that is, just the opposite strategy to that carried 
out by Goda et al.. The antibodies obtained were only tested against NP, and an indirect 
ELISA and a homogeneous PFIA have been developed; the LODs achieved by PFIA 
were almost 2 orders of magnitude higher (Table 1) than in the ELISA. Unfortunately 
there is a lack of information regarding antibody specificity for OP, APEs, or even 
APECs. This aspect would be interesting in order to discuss the differences encountered 
when using hapten A or B for raising antibodies. 
Antibodies able to recognize all alkylphenolic compounds (including APEs and APs) 
could be enough depending on the requirements. However, specific antibodies only for 
NP would be still more useful, since this is the most estrogenic and persistent compound 
of the APEs and therefore more exhaustive and rapid controls are required to determine 
accurate levels in the environment. Finally, it can also be noted that for NP the 
sensitivities of the techniques developed are generally worse than for APEs. In most 
cases the dynamic range or the IC50 are in the order of the mg L
–1
. The hydrophobicity 
of NP, which is quite high (logP=4.5), may explain the low sensitivity reached by these 
methods regarding APs. Since immunochemical techniques work by definition in 
aqueous media and the extent of organic solvent tolerated for the technique is usually 
very low (10–20%), hydrophobic substances are sometimes difficult to measure. In 
these assay conditions NP probably presents problems of solubility or even of 
unspecific adsorption on the surfaces where the assay is carried out. These sensitivities 
are maybe enough for samples coming from wastewater, where the levels of NP are 
quite high, but for surface and groundwater more sensitive methods are still needed. 
Phthalate esters 
Phthalate esters have been extensively used as plasticizers in PVC production as well as 
a component in the manufacture of cosmetic products, adhesives, solvents, and inks. 
Several phthalates are used such as diethylhexylphthalate (DEHP), butylbenzylphthalate 
(BBP), dibutylphthalate (DBP), and dioctylphthalate (DOP). The most important one is 
DEHP, which represents over 90% of the total phthalates production, approximately 
54,000 t year
–1
 [82, 83]. The PVC resins have been used to manufacture a wide variety 
of products, from shower curtains, raincoats defoaming agents, animal glue, and 
enclosures for food containers to pacifiers, soft squeeze toys, and teething rings. The 
phthalates may then enter in the environment and food chain. Their fast biodegradation 
under aerobic conditions prevents their accumulation in water (the half-life is about 
several hours to 15 days) while in sediments it can be more persistent (with a half-life 
between 7 days and several months) [84]. It is well known that phthalates are testicular 
toxicants [85, 86]. Concerning their disrupting effect, different in vitro studies have 
confirmed that phthalates such as BBP and DBP are weakly estrogenic [73, 87] (BBP is 
the phthalate with a highest activity and is 1-milion-fold less potent that the natural 
estrogen 17β-estradiol [88]). In vivo experiments have found that DBP and DEHP cause 
irregularities in male sexual differentiation [89, 90] and DBP have a weakly estrogenic 
activity although it seems that these possible effects occur at high concentrations [91]. 
Contradictory results have been found about the mechanism of action of these disrupters, 
since several studies seem to indicate that some phthalates act as antiestrogens [92]. 
Recently, Moore [93] has published a review with the current available data about the 
potential effects of phthalates. Phthalates have been found in industrial effluents, 
sewage sludges, and are also found in groundwater and drinking water [87]. The 
environmental levels found are approximately 10 μg L–1 in surface waters, 0.5–1 μg L–1 
in rivers, and 0.005–0.7 μg L–1 in seawater. 
Immunochemical techniques for phthalate esters 
The methods currently used to measure phthalate esters quantitatively are GC and 
HPLC. In addition, a few references report the use of immunochemical techniques. The 
first one [94] describes the development of a time-resolved fluoroimmunoassay (TR-
FIA) capable of measuring several phthalates: dimethylphthalate, diethylphthalate, DBP, 
BBP, and DOP in water. The polyclonal antisera were obtained by immunizing with the 
molecule 2A (Scheme 2), which keeps the dimethylester group intact. The time of the 
assay is less than 3 h and the sensitivity achieved is good, with an LOD of about 
97 ng L
–1
 for dimethylphthalate and a working range of between 97 ng L
–1
 and 
388 μg L–1. The labels used in this type of immunoassay are europium chelates. These 
have interesting fluorescent properties such as a decay time that is much longer (near to 
hundreds of milliseconds) than other organic molecules (the values are in the 
nanoseconds range), which leads to good sensitivities. Although the most produced and 
used phthalate, DEHP, has not been tested, other important phthalates like BBP and 
DBP, and another octylphthalate (DOP) can be analyzed with this technique with good 
sensitivity and specificity. Moreover, little interference due to isomeric phthalic esters 
has been found, whereas phthalic acids are not recognized by the antisera used in the 
assay.  
 
Scheme 2A,B  Chemical structures of the two immunizing haptens used to raise antibodies for 
phthalate esters. A Hapten used by Ius et al. [94] to obtain polyclonal antibodies. B Hapten used 
by Goda et al. [76] to obtain monoclonal antibodies  
 
On the other hand, Goda et al. [76] have developed a direct ELISA using specific 
monoclonal antibodies. By using DBP as standard, an assay with a limit of detection of 
200 μg L–1 has been obtained. The dynamic range is 200–4,000 μg L–1. The sensitivity 
is not very good, and a possible reason could be the selection of the immunizing hapten. 
In this case the spacer arm has been introduced in both esters, blocking the two 
important epitopes in the molecule (structure 2B in Scheme 2). Regarding to the 
selectivity of the assay, the antibodies show good specificity for both BBP and DBP, 
but also in this case DEHP is not recognized. Thus, more attempts are needed to obtain 
immunochemical methodologies capable of detecting this main phthalate. 
Bisphenol A 
Bisphenol A [2,2-bis (4-hydroxydiphenyl)propane, BPA)] is a major component in the 
production of polycarbonate plastics and epoxy resins. These materials are used for 
several applications such as in food and drink plastic packages, food can linings, and 
dental composite fillings. Other minor uses involve its application as antioxidant, 
preservative, and in the production of flame-retardant components. However, the 
production of resins remains the most common application area. Incomplete 
polymerization or partial hydrolysis of the polymers leads to release of bisphenol A 
from the flasks into food; this is the origin of human exposure to BPA [95, 96]. 
Bisphenol A is not only a food contaminant but also an environmental pollutant, since 
its presence has been detected in sewage effluents, with values often below 1 μg L–1 [97, 
98], and in surface water, with concentrations even lower (in the range 0.001–1 μg L–1) 
[97, 99]. However, the biodegradation of bisphenol A is quite rapid in surface water 
(with a half-life of 0.5–6 days) [100, 101] and also in rivers sediments (although it has 
been detected [99]), and is extensively removed in the wastewater treatment plants 
(WWTPs). Apart of acute toxicity, the disrupting effects of bisphenol A have been 
studied for several years [4]: BPA has weak estrogenic activity at concentrations of 
about 2–5 μg L–1 [96]. Also a possible antiandrogenic activity seems to be caused by 
BPA [92]. Several studies have shown that BPA induces alteration in reproductive 
organs in female rats [102] as well as in male mice, rats [103], and fish [104]. Because 
of its human exposure risk and its evident disrupting effect, several methods have been 
developed to detect BPA, such as GC-MS [105], HPLC-UV [106], or HPLC-MS [74, 
75], not only in environmental samples but also in beverages [107], serum [108], and 
semen [109]. 
Immunochemical techniques for bisphenol A 
Many more attempts have been carried out to develop sensitive immunochemical 
methods for BPA than for the other ECDs considered in this review as summarized in 
Table 2. Goda et al. have also produced monoclonal antibodies and developed a direct 
ELISA with a limit of detection of 5 μg L–1 [76]. In the immunizing hapten the spacer 
arm has been introduced in the position occupied by one hydroxyl group in BPA (see 
hapten 3A in Scheme 3). The working range of the assay is 5–500 μg L–1. Only two 
different bisphenolic compounds, those who have either one or two hydrogen atoms 
instead of the methyl groups, are well recognized with cross-reactivities of 144% and 
73%, respectively, whereas metabolites of BPA and other related compounds do not 
interact with the antibodies. These high cross-reactivities are not a problem, since both 
compounds are produced in much lower amounts than BPA. An optimized ELISA kit 
with monoclonal antibodies has also been commercialized by Takeda Chemical 
Industries. In this case, a more sensitive assay has been achieved with a dynamic range 
of 0.05–10 μg L–1. Related bisphenolic compounds, other EDCs, surfactants, and fumic 
acids have been tested and no cross-reactivity has been observed.  
Table 2  Immunochemical techniques developed for the detection of bisphenol A  
Compound 
Immunochemical 
technique 
LOD
a
/IC50 
b 
(μg L–1) 
Working 
range (μg L–1) 
Comments Ref 
Bisphenol 
A 
Direct ELISA 5
a
  5–500 Monoclonal Ab [76] 
Commercial Direct 
ELISA Kit 
0.05
a
  0.05–10 Monoclonal Ab [78] 
Automated BMP-IA 0.0023
a
  0.0023–2,300 Commercial monoclonal Ab [81] 
Indirect ELISA 570
b
  nr
c
  Chicken polyclonal Ab [110] 
Indirect ELISA 0.1
a
  1–10,000 Polyclonal Ab [111] 
IAC – – Extraction of BPA from [112] 
Compound 
Immunochemical 
technique 
LOD
a
/IC50 
b 
(μg L–1) 
Working 
range (μg L–1) 
Comments Ref 
serum samples using 
polyclonal Ab 
Direct ELISA 0.3
a
  0.3–100 Polyclonal Ab  [113] 
a
 LOD limit of detection 
b
IC50  
c
 nr not reported 
ELISA enzyme linked immunosorbent assay 
BMP-IA bacterial magnetic particles based immunoassay 
IAC immunoaffinity chromatography 
 
Scheme 3A–C  Chemical structures of several immunizing haptens used to obtain antibodies 
against bisphenol A. A Hapten used to produce both monoclonal [76] and polyclonal [110] 
antibodies by Goda et al. and DeMeulenaer et al., respectively. B Hapten used to produce 
polyclonal antibodies by Zhao et al. [111]. C Different haptens used to obtain polyclonal 
antibodies [113] by Ohkuma et al.  
 
As in the case of APEs, Matsunaga et al. [81] have developed an automated 
immunoassay based on the immobilization of these monoclonal antibodies on bacterial 
magnetic particles. The sensitivity of this assay is very good with a detection range of 
2.3 ng L
–1
 to 2.3 mg L
–1
, that is, even better than the direct ELISA and conventional 
chromatographic methods. 
Other attempts have been carried out to obtain specific antibodies. De Meulenaer et al. 
[110] have developed an indirect competitive ELISA with polyclonal antibodies 
obtained from chicken egg yolk. The immunizing hapten conjugated to BSA is the same 
one used by Goda et al. (hapten 3A in Scheme 3). Several parameters in the assay have 
been optimized to finally obtain an ELISA with an IC50 value of about 570 μg L
–1
. Also, 
several other bisphenol and phenolic compounds and phthalates have been tested 
observing that only two bisphenolic compounds were recognized with a maximum 
value of 43% cross-reactivity for the bisphenol with only one hydroxyl group. Better 
results have been obtained by Zhao et al. [111] who produced polyclonal antibodies 
against the hapten 3B shown in Scheme 3. In this case, both hydroxyls groups in the 
molecule have been preserved and the analyte has been derivatized by one of the methyl 
groups. An indirect ELISA has been obtained with a linear range of 1–10,000 μg L–1 
and a limit of detection of 0.1 μg L–1 on real water samples. Serum samples have been 
also analyzed, and a dilution factor of 1:10 was needed. The limit of detection achieved 
in this case was 2 μg L–1. Phenolphthalein, as a structure that has the bisphenol pattern, 
has been evaluated and shows little cross-reactivity. The antibodies did not recognize 
other simple phenolic compounds tested. Subsequently, these antibodies were also used 
to develop immunoaffinity columns for the selective extraction of bisphenol A from 
serum samples [112] to obtain an analyte recovery value of about 90%. 
Ohkuma et al. have also developed a direct ELISA [113] with a limit of detection of 
0.3 μg L–1 for human serum samples, and a working range of 0.3–100 μg L–1. Several 
haptens based on the formation of carboxyalkylethers, such as methyl, propyl, and 
butylethers, were prepared in order to raise antibodies in rabbits. The analyte recoveries 
found in spiked serum samples were 82–97%, without important nonspecific matrix 
effects. The specificity of the assay was good since only bisphenol B (with an ethyl 
group instead of one of the two methyl substituents in bisphenol A) interfered in the 
assay with a cross-reactivity value of 13%. 
Finally, immunochemical methods have been developed using monoclonal antibodies 
selected for their high resistance to organic solvent (up to 50% of methanol). Assays 
could be run in these conditions at levels of around 1 μg L–1. Other polyclonal 
antibodies were used to selectively detect bisphenol A in urine samples at concentration 
levels of 0.5–5 μg L–1 [114]. 
Polychlorinated biphenyls (PCBs) 
Polychlorinated biphenyls (PCBs) are one of the most hazardous, persistent, and toxic 
man-made compounds. They are a class formed by 209 discrete congeners in which 1–
10 chlorine atoms can be bound to the biphenyl nucleus. They were produced until the 
1970–1980s, when their toxic effects began to be discovered. Since the 1930s, these 
compounds were commercialized as mixtures of several congeners (with commercial 
names like Aroclor, Clophen, etc.) and were widely used in many industrial applications 
such as lubricants, dielectric fluids in electrical transformers and capacitors, hydraulic 
fluids, and as additives in plastics, adhesives, sealants, and copying paper. They are 
inert, heat resistant, and nonflammable and these properties make the compounds of this 
family very persistent in the environment. Their high hydrophobicity leads to adsorption 
mainly in sediments, soils, and sludge. They are also bioaccumulated in adipose tissue 
and in milk [12]. The human exposure comes mainly from indirect exposure through 
food (fish) and mother s milk. 
PCBs can be coplanar or noncoplanar and they differ in their toxicology. Only 12 of the 
209 congeners seem to have a toxic level similar to dioxins, and all of them are called 
coplanar PCBs. They have no, or just one, chlorine atom in the ortho position, two 
chlorines in para positions, and at least one in a meta position. Three of the most toxic 
congeners are less abundant and are 3,4,3’,4’-tetrachlorobiphenyl (PCB 77), 
3,4,3’,4’,5’-pentachlorobiphenyl (PCB 129), and 3,4,5,3’,4’,5’-hexachlorobiphenyl 
(PCB 169). The toxicology of these compounds include carcinogenic, tetarogenic, 
tumorigenic reproductive and immunotoxic effects, and they also have disrupting 
effects causing reproductive alterations, endometriosis, thyroid dysfunction, increase in 
uterus weight, or ovarian growth impairment [12, 115, 116, 117]. PCBs can also 
undergo anaerobic reductive dehalogenation in river sediments [118]. It seems that their 
hydroxylated metabolites can also induce an estrogenic effect [73, 119]. 
This family of products has been extensively studied in recent years and has been 
analyzed with conventional techniques (e.g., GC-MS) that usually require clean-up and 
pretreatment process in order to separate the most toxic congeners, which often are the 
analyte of interest. 
Immunochemical techniques for PCBs 
Although PCBs are highly lipophilic and the immunochemical techniques require an 
aqueous media to be carried out, several attempts have been made to obtain specific 
antibodies against PCBs and to develop immunoassays for their detection and 
quantification. The first ones date from the 1980s [120, 121] and some later studies are 
briefly reviewed by Diaz-Ferrero et al. [122]. Often these assays have been developed 
not for the detection of specific congeners but for the detection of commercial products 
like Aroclor, and the immunizing hapten is the derivatized Aroclor or a PCB congener. 
Several radioimmunoassays (RIAs) have been developed using polyclonal antibodies 
and have been used to detect Delor 106 in milk [123] and Aroclor 1248 in milk and 
blood [29, 124]. Other immunoassays have also been reported to detect Aroclors or the 
most abundant and also less toxic noncoplanar PCBs in soil, water, and sediments (see 
Table 1 in ref. [122]) [125, 126, 127, 128]. 
More recently, other immunochemical techniques have been reported for the detection 
of PCBs. Johnson et al. [129] obtained polyclonal antibodies for Aroclor by using 
hapten 4A (Scheme 4) as the immunizing hapten. An indirect competitive microtiter 
plate ELISA was developed. Several Aroclors were tested and the most recognized ones 
were Aroclor 1242, 1248, 1254, 1260, and 1262 with IC50 values of 10–31 μg L
–1
 and 
limits of detection of around 1.3 μg L–1 in water and 9 ng g–1 in soil. The specificity of 
the assay was also tested using a great variety of compounds as potential cross-reactants 
(chlorophenols, chloroanisols, chlorobenzenes, etc.) showing that none of them was 
recognized more than 3%.  
 
Scheme 4A–C  Chemical structures of two immunizing haptens used to raise antibodies 
towards PCBs. A Hapten used by Johnson et al. [129] to obtain polyclonal antibodies. B Hapten 
used by Chiu et al. [131] to obtain monoclonal antibodies against coplanar PCBs. C Mixtures of 
haptens used by Concejero et al. [132] to raise polyclonal antibodies  
 
Lawruk et al. [130] have developed a magnetic particle-based immunoassay using 
Aroclor 1254 as the immunizing hapten to obtain polyclonal antibodies. The limit of 
detection of the assay is of 0.2 μg L–1 in water and 500 μg Kg–1 in soil. Several Aroclors 
cross-reacted, and also PCB 129 (3,4,3 ,4 ,5 -pentachlorobiphenyl) was well 
recognized. The assay can provide 50 analytical results in less than 1 h, and its 
feasibility allows its adaptation to on-line monitoring of PCBs in water and soils. 
To the best of our knowledge, most of the immunoassays reported have used polyclonal 
antibodies for the detection of Aroclors. Only one attempt has been reported based on 
the production of monoclonal antibodies used to detect the specific coplanar PCB 
congeners which are the most toxic and the less abundant: PCB 77,126, and 169 [131]. 
The immunizing hapten 4B is shown in Scheme 4 and was chosen because of the 
substitution pattern (3,4,3’,4’) that is common in the three congeners considered. Also, 
the spacer arm in the para position allowed the coplanarity of the biphenyls to be 
retained. Both direct and indirect competitive assays were developed and the best results 
were obtained for PCB 77 and 126 (around 1 μg L–1). The specificity of the assay is 
high since several noncoplanar PCBs were tested and were poorly recognized. Also 
PCDD, PCDF, and PCB metabolites were evaluated and were not recognized. 
By using the same kind of immunizing hapten (with one carbon less in the spacer arm 
than described by Chiu et al. [131]), Concejero et al. [132] recently produced polyclonal 
antibodies to prepare immunoaffinity columns. An immunoaffinity chromatography 
procedure has been developed to selectively clean up and isolate liquid PCB samples 
prior to GC-MS analysis. In particular, coplanar PCBs and the most toxic PCDSs and 
PCDFs were extracted with high recoveries. 
Several PCB antibodies and PCB immunoassay kits are commercially available with 
different formats and applications. Some of them are performed in coated test tubes 
such as the EnviroGard PCB Test Kit or EnSys (SDI Europe Ltd., UK), in magnetic 
particles such as the PCB RaPID Assay (SDI Europe Ltd., UK). There are also latex 
particles/membrane immunoassay kits (D Tech, SDI Europe Ltd., UK). All of them are 
rapid and simple methods and allow the analysis of water samples and soil and wipe 
matrices but work at semiquantitative or qualitative levels. By using commercial 
monoclonal antibodies an indirect ELISA has been developed to detect PCBs in 
insulating oils [133]. The optimized assay presents a working range for Aroclors 1254 
and 126 of 30–1,000 μg L–1, an IC50 value near to 215 μg L
–1
, and an LOD of about 
25 μg L–1 and 40 μg L–1 for Aroclor 1254 and 1260, respectively. 
Finally, a fiber optic immunosensor has been developed for PCBs detection [63], with a 
sensitivity limit for Aroclor 1242 of 10 μg L–1. Other Aroclors are also recognized, 
whereas polychlorophenols, polychlorobenzenes, and other chlorinated compounds 
have a low degree of cross-reactivity. 
Polychlorinated dibenzofurans (PCDFs) and 
polychlorinated dibenzo-p-dioxins (PCDDs) 
Both PCDDs and PCDFs (commonly referred to as dioxins) are a group of widespread 
environmental pollutants of great concern during recent years due to their harmful 
effects for the health. As well as for PCBs, many congeners exist depending on the 
number and position of the chlorine atoms (75 for dioxins and 135 for furans). These 
pollutants have a high chemical stability and extremely poor water solubility (about 
20 ng L
–1
 for TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin). But, unlike PCBs, these 
recalcitrant and persistent compounds are not produced intentionally, but are generated 
as undesired by-products in several processes, mainly combustion processes such as 
waste incineration. Other sources of dioxins are from bleaching of pulp with chlorine, 
metal production, and synthesis of halogenated compounds such as chlorophenols. Due 
to their highly lipophilic nature, these compounds tend to be adsorbed and accumulated 
in sediments and soils. On the other hand, wildlife and human exposure comes from the 
emission at production and at waste stage (incineration) and through food (they have 
been found in fish, meat, and other dairy products) and mother s milk. 
The most toxic dioxin seems to be TCDD and is proven to cause cancer in humans 
[134]. The effects of the other congeners depend on the position and number of chlorine 
atoms and it seems that the 2,3,7,8 chlorination pattern is required for dioxin-like 
toxicity. TCDD and other PCDDs and PCDFs have been shown to induce disrupting 
effects [135], such as the reduction of fertility due to their action on the hormones of the 
reproductive system, thyroid effects, decrease of sperm number in males and uterus 
weight in females. 
The ubiquity of these substances in the environment and their clearly demonstrated 
toxicity have led to continuous analysis by different methodologies. Of these, high-
resolution gas chromatography coupled to mass spectrometry (HRGC-HRMS) was the 
most used until several years ago. During recent decades much effort has been made in 
biotechnology in order to develop in vitro bioassays and ligand binding assays that may 
allow the analysis of large numbers of samples as well as an improvement in the 
accuracy and reliability of the results. An extensive review with the recent bioanalytical 
techniques developed for dioxin detection, including immunoassays, has been recently 
reported [136]. 
Immunochemical techniques for PCDFs and PCDDs 
As well as in the case of PCBs and other compounds, the high hydrophobicity of these 
substances may imply a drawback in the application of immunochemical techniques for 
their detection and several considerations must be taken into account such as the hapten 
design, the organic solvent compatibility, and the handling of the standard solutions. In 
the literature, complete reviews can be found focusing on the immunochemical analysis 
of dioxins, paying special attention to antibody production, sample preparation, clean-
up methods, sensitivity of immunoassays developed, etc. as well as in immunoassays 
and other bioassays for polychlorinated compounds [122, 137]. 
The first immunochemical technique reported for detection of dioxins was in 1979 and 
was a RIA [138] developed with polyclonal antibodies. The method developed was very 
time-consuming and both dioxins and furans were well recognized. Further optimization 
was carried out to improve the assay sensitivity and precision [139] using solubilization 
agents. Later Kennel et al. [140] obtained monoclonal antibodies that successfully 
recognized carrier-protein-bound dioxins but not the free form in solution. The assay 
was performed with a solid-phase RIA configuration. Other immunoassays using 
monoclonal antibodies were developed in the 1980s by Stanker et al. [141, 142] that 
were applied to detect dioxins in soils [143] and for rapid screening of dioxins and 
furans [144, 145, 146, 147]. These ELISAs had a sensitivity similar to the RIA (an IC50 
value about 200 pg TCDD well
–1
). Langley et al. [148] also reported an ELISA with 
polyclonal antibodies with a sensitivity of 1 ng well
–1
 using 2,3,7,8-TCDD as standard. 
More recent works have focused on the design and synthesis of new haptens to improve 
the already existing IAs or to produce more specific antibodies [149]. Sugawara et al. 
[150] have also obtained specific polyclonal antibodies against PCDDs, and have 
developed an indirect competitive ELISA with high sensitivity (the IC50 value is of 
240 ng L
–1
 and a working range of 40–4,800 ng L–1). Several PCDDs and even PCDFs 
are well recognized, mainly those with the 2,3,7,8 substitution pattern. Subsequently 
Shan et al. [151] improved this immunoassay by using a different coating antigen and 
obtained a more sensitive ELISA with a LOD of 4 ng L
–1
 and an IC50 value of 36 ng L
–1
. 
During recent years several works have been reported on the development of 
immunoaffinity columns for selective extraction of dioxins and furans. Both 
monoclonal [152] and chicken polyclonal antibodies [153] have been used to prepare 
the immunosorbents. The immunoaffinity column procedures were optimized to 
subsequently isolate and analyze these compounds from serum samples and the 
recoveries for both columns have also been compared [154]. Finally, several 
commercial dioxin immunoassay kits are available (e.g., Envirogard, EnSys, and Dioxin 
RISC from SDI Europe Ltd., UK; DD3 from Millipore Inc., USA and High 
Performance dioxin/furan EIA from CAPE Technologies, USA). 
 
Conclusions 
It has been widely demonstrated that immunochemical techniques offer a good 
alternative to conventional methodologies in many areas due to the high sensitivity and 
selectivity achieved for the antibodies towards the target analytes. In clinical and 
environmental analysis, their use has been broadly spread because of their sensitivity, 
specificity, and high sample processing capabilities. For the case of man-made 
pollutants with endocrine disrupting activity and high risk of human and wildlife 
exposure presented in this review, a variety of immunochemical methods have been 
developed covering sample treatment methods (i.e., immunosorbents) and analytical 
methods such as several immunoassays formats (RIA, ELISA, PFIA, FIIA) and 
immunosensors. For human and environmental safety reasons, the use of RIA methods 
has been dismissed in favor of the assays using enzymes or 
fluorescent/chemiluminescent labels. Unfortunately, some of these methods are not yet 
being used as regular screening and analytical methods in food-safety and 
environmental control laboratories. A reason for this may be the lack of knowledge on 
the performance of this type of techniques by certain analytical sectors and also by the 
lack of validated protocols for a wide range of sample matrices. Immunoassay methods 
may suffer from undesirable matrix effects that may lead to wrong positive or negative 
results. It is an incorrect assumption that the selectivity of the immunochemical reaction 
is sufficiently high enough to overcome nonspecific interactions of the antibodies with 
the matrix components. Rigorous evaluation of the performance of these methods on 
each sample matrix of interest and the consequent establishment of appropriate sample 
treatment methods are required to ensure reliability and to convince control laboratories 
of the efficiency of these techniques. A tight collaboration and interchange of expertise 
between analytical chemists and immunochemists are needed to accomplish this goal 
and to take advantage of these methods to assess risk and protect public health from the 
adverse effects of these types of pollutants. 
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